Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

According to Research by SNS Insider, Organ-on-a-Chip Market growth is driven by advancements in biotechnology, increasing demand for drug testing alternatives, and rising investments in organ ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to discover new molecules and potential therapies. Pfizer is partnering with ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

There are plenty of different alternatives for anyone looking to add a skin serum to their routine. At Superdrug, there's the ...

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...

Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in a fireside chat and investor ...

PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business ...

Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.